Targeted Genetics Corporation – ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF AMPLIPHI BIOSCIENCES CORPORATION (A Washington Corporation) (April 24th, 2017)
Pursuant to the provisions of the Washington Business Corporation Act, RCW 23B.10.020 and RCW 23B.10.060, the undersigned corporation hereby submits these Articles of Amendment for filing:
Targeted Genetics Corporation – AmpliPhi Biosciences Corporation Amendment to Offer Letter Agreement (April 4th, 2017)
This Amendment to Offer Letter Agreement (this "Amendment") is entered into by and between AmpliPhi Biosciences Corporation (the "Company") and M. Scott Salka (hereinafter "Employee") effective as of April 1, 2017 (the "Effective Date"), and as of the Effective Date amends the terms of the Offer Letter Agreement entered into by and between the Company and Employee dated April 24, 2015 (the "Agreement").
Targeted Genetics Corporation – Amendment to Consulting Agreement (September 29th, 2016)
This Amendment to Consulting Agreement (the "Amendment") is made as of September 27, 2016, by and between AmpliPhi Biosciences Corporation, a Washington corporation (the "Company"), and Wendy S. Johnson (the "Consultant"). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Consulting Agreement (as defined below).
Targeted Genetics Corporation – Placement Agency Agreement (June 1st, 2016)
Targeted Genetics Corporation – Ampliphi Biosciences Corporation Common Stock Issuance Agreement (April 8th, 2016)
This Common Stock Issuance Agreement (this "Agreement") is made as of April 8, 2016, by and among AmpliPhi Biosciences Corporation, a Washington corporation (the "Company"), and the persons and entities listed on Exhibit A hereto (each, a "Holder" and collectively, the "Holders").